Modelling the incidence of Plasmodium vivax and Plasmodium falciparum malaria in Afghanistan 2006-2009
Background Identifying areas that support high malaria risks and where populations lack access to health care is central to reducing the burden in Afghanistan. This study investigated the incidence of Plasmodium vivax and Plasmodium falciparum using routine data to help focus malaria interventions....
| Hlavní autoři: | , , , , , , , , |
|---|---|
| Médium: | Journal article |
| Jazyk: | English |
| Vydáno: |
Public Library of Science
2014
|
| _version_ | 1826260402900566016 |
|---|---|
| author | Alegana, V Wright, J Nahzat, S Butt, W Sediqi, A Habib, N Snow, R Atkinson, P Noor, A |
| author_facet | Alegana, V Wright, J Nahzat, S Butt, W Sediqi, A Habib, N Snow, R Atkinson, P Noor, A |
| author_sort | Alegana, V |
| collection | OXFORD |
| description | Background Identifying areas that support high malaria risks and where populations lack access to health care is central to reducing the burden in Afghanistan. This study investigated the incidence of Plasmodium vivax and Plasmodium falciparum using routine data to help focus malaria interventions. Methods To estimate incidence, the study modelled utilisation of the public health sector using fever treatment data from the 2012 national Malaria Indicator Survey. A probabilistic measure of attendance was applied to population density metrics to define the proportion of the population within catchment of a public health facility. Malaria data were used in a Bayesian spatio-temporal conditional-autoregressive model with ecological or environmental covariates, to examine the spatial and temporal variation of incidence. Findings From the analysis of healthcare utilisation, over 80% of the population was within 2 hours’ travel of the nearest public health facility, while 64.4% were within 30 minutes’ travel. The mean incidence of P. vivax in 2009 was 5.4 (95% Crl 3.2–9.2) cases per 1000 population compared to 1.2 (95% Crl 0.4–2.9) cases per 1000 population for P. falciparum. P. vivax peaked in August while P. falciparum peaked in November. 32% of the estimated 30.5 million people lived in regions where annual incidence was at least 1 case per 1,000 population of P. vivax; 23.7% of the population lived in areas where annual P. falciparum case incidence was at least 1 per 1000. Conclusion This study showed how routine data can be combined with household survey data to model malaria incidence. The incidence of both P. vivax and P. falciparum in Afghanistan remain low but the co-distribution of both parasites and the lag in their peak season provides challenges to malaria control in Afghanistan. Future improved case definition to determine levels of imported risks may be useful for the elimination ambitions in Afghanistan. |
| first_indexed | 2024-03-06T19:05:04Z |
| format | Journal article |
| id | oxford-uuid:14d7b8f8-084e-4a3f-a049-db83171f6b32 |
| institution | University of Oxford |
| language | English |
| last_indexed | 2024-03-06T19:05:04Z |
| publishDate | 2014 |
| publisher | Public Library of Science |
| record_format | dspace |
| spelling | oxford-uuid:14d7b8f8-084e-4a3f-a049-db83171f6b322022-03-26T10:22:10ZModelling the incidence of Plasmodium vivax and Plasmodium falciparum malaria in Afghanistan 2006-2009Journal articlehttp://purl.org/coar/resource_type/c_dcae04bcuuid:14d7b8f8-084e-4a3f-a049-db83171f6b32EnglishSymplectic Elements at OxfordPublic Library of Science2014Alegana, VWright, JNahzat, SButt, WSediqi, AHabib, NSnow, RAtkinson, PNoor, ABackground Identifying areas that support high malaria risks and where populations lack access to health care is central to reducing the burden in Afghanistan. This study investigated the incidence of Plasmodium vivax and Plasmodium falciparum using routine data to help focus malaria interventions. Methods To estimate incidence, the study modelled utilisation of the public health sector using fever treatment data from the 2012 national Malaria Indicator Survey. A probabilistic measure of attendance was applied to population density metrics to define the proportion of the population within catchment of a public health facility. Malaria data were used in a Bayesian spatio-temporal conditional-autoregressive model with ecological or environmental covariates, to examine the spatial and temporal variation of incidence. Findings From the analysis of healthcare utilisation, over 80% of the population was within 2 hours’ travel of the nearest public health facility, while 64.4% were within 30 minutes’ travel. The mean incidence of P. vivax in 2009 was 5.4 (95% Crl 3.2–9.2) cases per 1000 population compared to 1.2 (95% Crl 0.4–2.9) cases per 1000 population for P. falciparum. P. vivax peaked in August while P. falciparum peaked in November. 32% of the estimated 30.5 million people lived in regions where annual incidence was at least 1 case per 1,000 population of P. vivax; 23.7% of the population lived in areas where annual P. falciparum case incidence was at least 1 per 1000. Conclusion This study showed how routine data can be combined with household survey data to model malaria incidence. The incidence of both P. vivax and P. falciparum in Afghanistan remain low but the co-distribution of both parasites and the lag in their peak season provides challenges to malaria control in Afghanistan. Future improved case definition to determine levels of imported risks may be useful for the elimination ambitions in Afghanistan. |
| spellingShingle | Alegana, V Wright, J Nahzat, S Butt, W Sediqi, A Habib, N Snow, R Atkinson, P Noor, A Modelling the incidence of Plasmodium vivax and Plasmodium falciparum malaria in Afghanistan 2006-2009 |
| title | Modelling the incidence of Plasmodium vivax and Plasmodium falciparum malaria in Afghanistan 2006-2009 |
| title_full | Modelling the incidence of Plasmodium vivax and Plasmodium falciparum malaria in Afghanistan 2006-2009 |
| title_fullStr | Modelling the incidence of Plasmodium vivax and Plasmodium falciparum malaria in Afghanistan 2006-2009 |
| title_full_unstemmed | Modelling the incidence of Plasmodium vivax and Plasmodium falciparum malaria in Afghanistan 2006-2009 |
| title_short | Modelling the incidence of Plasmodium vivax and Plasmodium falciparum malaria in Afghanistan 2006-2009 |
| title_sort | modelling the incidence of plasmodium vivax and plasmodium falciparum malaria in afghanistan 2006 2009 |
| work_keys_str_mv | AT aleganav modellingtheincidenceofplasmodiumvivaxandplasmodiumfalciparummalariainafghanistan20062009 AT wrightj modellingtheincidenceofplasmodiumvivaxandplasmodiumfalciparummalariainafghanistan20062009 AT nahzats modellingtheincidenceofplasmodiumvivaxandplasmodiumfalciparummalariainafghanistan20062009 AT buttw modellingtheincidenceofplasmodiumvivaxandplasmodiumfalciparummalariainafghanistan20062009 AT sediqia modellingtheincidenceofplasmodiumvivaxandplasmodiumfalciparummalariainafghanistan20062009 AT habibn modellingtheincidenceofplasmodiumvivaxandplasmodiumfalciparummalariainafghanistan20062009 AT snowr modellingtheincidenceofplasmodiumvivaxandplasmodiumfalciparummalariainafghanistan20062009 AT atkinsonp modellingtheincidenceofplasmodiumvivaxandplasmodiumfalciparummalariainafghanistan20062009 AT noora modellingtheincidenceofplasmodiumvivaxandplasmodiumfalciparummalariainafghanistan20062009 |